Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Oncotarget
|
September 17, 2014
Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics
Cecilia Evangelisti, Camilla Evangelisti, Gabriella Teti, et al.
Oncotarget
|
August 28, 2016
Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression
Sandra Durante, Silvia Vecchiarelli, Annalisa Astolfi, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 9, 2020
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes
Stefano Ratti, Isabella Rusciano, Sara Mongiorgi, et al.
Oncotarget
|
December 29, 2012
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia
Francesca Chiarini, Annalisa Lonetti, Gabriella Teti, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Oncotarget
|
September 17, 2014
Assessment of the effect of sphingosine kinase inhibitors on apoptosis,unfolded protein response and autophagy of T-cell acute lymphoblastic leukemia cells; indications for novel therapeutics
Cecilia Evangelisti, Camilla Evangelisti, Gabriella Teti, et al.
Oncotarget
|
August 28, 2016
Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression
Sandra Durante, Silvia Vecchiarelli, Annalisa Astolfi, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 9, 2020
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes
Stefano Ratti, Isabella Rusciano, Sara Mongiorgi, et al.
Oncotarget
|
December 29, 2012
A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia
Francesca Chiarini, Annalisa Lonetti, Gabriella Teti, et al.
Page
of 7